Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00299936
Recruitment Status : Completed
First Posted : March 7, 2006
Last Update Posted : March 7, 2006
Information provided by:
Weill Medical College of Cornell University